{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:03:21Z","timestamp":1779174201794,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,4,10]]},"DOI":"10.3233\/jad-170775","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T12:29:48Z","timestamp":1521808188000},"page":"115-130","source":"Crossref","is-referenced-by-count":14,"title":["Comprehensive Characterization of the Pyroglutamate Amyloid-\u03b2 Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice"],"prefix":"10.1177","volume":"63","author":[{"given":"Tina","family":"Dunkelmann","sequence":"first","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Schemmert","sequence":"additional","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Honold","sequence":"additional","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Teichmann","sequence":"additional","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Butzk\u00fcven","sequence":"additional","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Ulrich","family":"Demuth","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Target Validation (MWT), Fraunhofer-Institute of Cell Therapy and Immunology (IZI), Leipzig, Biozentrum, Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadim Joni","family":"Shah","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Medicine, Medical Imaging Physics, Forschungszentrum J\u00fclich GmbH, J\u00fclich Germany"},{"name":"Department of Neurology, Faculty of Medicine, JARA, RWTH Aachen University, Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Josef","family":"Langen","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Medicine, Medical Imaging Physics, Forschungszentrum J\u00fclich GmbH, J\u00fclich Germany"},{"name":"Department of Nuclear Medicine, Universit\u00e4tsklinikum der RWTH Aachen, Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Kutzsche","sequence":"additional","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Willbold","sequence":"additional","affiliation":[{"name":"Institute of Complex Systems, Structural Biochemistry, Forschungszentrum J\u00fclich GmbH, J\u00fclich, Germany"},{"name":"Institut f\u00fcr Physikalische Biologie, Heinrich Heine Universit\u00e4t D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Willuweit","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Medicine, Medical Imaging Physics, Forschungszentrum J\u00fclich GmbH, J\u00fclich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170775_ref1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-170775_ref2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jocn.2003.12.007","article-title":"Alzheimer\u2019s disease pathogenesis and therapeutic interventions","volume":"11","author":"Parihar","year":"2004","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JAD-170775_ref3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-170775_ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-170775_ref5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-6606-5-25","article-title":"Alzheimer\u2019s disease Abeta assemblies mediating rapid disruption of synaptic plasticity and memory","volume":"5","author":"Klyubin","year":"2012","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-170775_ref6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/bbrc.1997.7083","article-title":"Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits","volume":"237","author":"Kuo","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-170775_ref7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1570159X11311050004","article-title":"Pyroglutamate-modified amyloid beta peptides: Emerging targets for Alzheimer\u2019s disease immunotherapy","volume":"11","author":"Perez-Garmendia","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-170775_ref8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.biocel.2010.08.015","article-title":"Pyroglutamate-Abeta: Role in the natural history of Alzheimer\u2019s disease","volume":"42","author":"Gunn","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3233\/JAD-170775_ref9","doi-asserted-by":"crossref","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","article-title":"Pyroglutamate amyloid-beta (Abeta): A hatchet man in Alzheimer disease","volume":"286","author":"Jawhar","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170775_ref11","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1523\/JNEUROSCI.1794-11.2011","article-title":"Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Abeta is induced by pyroglutamate-Abeta formation","volume":"31","author":"Alexandru","year":"2011","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"10.3233\/JAD-170775_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-183X.2007.00373.x","article-title":"Motor impairment in Alzheimer\u2019s disease and transgenic Alzheimer\u2019s disease mouse models","volume":"7","author":"Wirths","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.3233\/JAD-170775_ref13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11065-007-9030-1","article-title":"Motor-skill learning in Alzheimer\u2019s disease: A review with an eye to the clinical practice","volume":"17","author":"van Halteren-van Tilborg","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"10.3233\/JAD-170775_ref14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/ern.11.57","article-title":"Loss of motor function in preclinical Alzheimer\u2019s disease","volume":"11","author":"Buchman","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-170775_ref15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s003359900551","article-title":"Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment","volume":"8","author":"Rogers","year":"1997","journal-title":"Mamm Genome"},{"key":"10.3233\/JAD-170775_ref16","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.3233\/JAD-170775_ref17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson\u2019s disease in rodents: A new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-170775_ref18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nprot.2006.20","article-title":"Digging and marble burying in mice: Simple methods for in vivo identification of biological impacts","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-170775_ref19","doi-asserted-by":"crossref","first-page":"13222","DOI":"10.1038\/srep13222","article-title":"QIAD assay for quantitating a compound\u2019s efficacy in elimination of toxic Abeta oligomers","volume":"5","author":"Brener","year":"2015","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-170775_ref20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.npep.2017.11.011","article-title":"Abeta oligomer eliminating compounds interfere successfully with pEAbeta(3-42) induced motor neurodegenerative phenotype in transgenic mice","volume":"67","author":"Dunkelmann","year":"2018","journal-title":"Neuropeptides"},{"key":"10.3233\/JAD-170775_ref21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/0269881111420313","article-title":"A comparison of InVivoStat with other statistical software packages for analysis of data generated from animal experiments","volume":"26","author":"Clark","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.3233\/JAD-170775_ref22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn.2432","article-title":"Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia","volume":"12","author":"Grathwohl","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-170775_ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","article-title":"Mouse models of Alzheimer\u2019s disease","volume":"88","author":"Hall","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-170775_ref24","doi-asserted-by":"crossref","first-page":"a006320","DOI":"10.1101\/cshperspect.a006320","article-title":"Animal models of Alzheimer disease","volume":"2","author":"LaFerla","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-170775_ref25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","article-title":"Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer\u2019s disease","volume":"127","author":"Bayer","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170775_ref26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","article-title":"Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson\u2019s disease","volume":"230","author":"Glajch","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-170775_ref27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/cdd.2008.172","article-title":"Astroglia in dementia and Alzheimer\u2019s disease","volume":"16","author":"Rodriguez","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.3233\/JAD-170775_ref28","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1113\/jphysiol.2012.246660","article-title":"The evolutionary origin of the vertebrate basal ganglia and its role in action selection","volume":"591","author":"Grillner","year":"2013","journal-title":"J Physiol"},{"key":"10.3233\/JAD-170775_ref29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-12-397920-9.00001-9","article-title":"Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits","volume":"109","author":"Pappas","year":"2014","journal-title":"Curr Top Dev Biol"},{"key":"10.3233\/JAD-170775_ref30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-142868","article-title":"Neuron loss and behavioral deficits in the TBA42 mouse model expressing n-truncated pyroglutamate amyloid-beta3-42","volume":"45","author":"Meissner","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170775_ref31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00401-013-1129-2","article-title":"N-truncated amyloid beta (Abeta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits","volume":"126","author":"Bouter","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170775_ref32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-009-0557-5","article-title":"Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model","volume":"118","author":"Wirths","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170775_ref33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","article-title":"Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model","volume":"165","author":"Casas","year":"2004","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-170775_ref34","first-page":"723782","article-title":"Neuron loss in transgenic mouse models of Alzheimer\u2019s disease","volume":"2010","author":"Wirths","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-170775_ref35","first-page":"e2609","article-title":"Measuring motor coordination in mice","author":"Deacon","year":"2013","journal-title":"J Vis Exp"},{"key":"10.3233\/JAD-170775_ref36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/nan.12440","article-title":"Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer\u2019s disease","volume":"43","author":"Ameen-Ali","year":"2017","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:10Z","timestamp":1777370770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":35,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-170775","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]}}}